N. Reginald Beer, Ph.D., Medical Diagnostics Initiative Leader, Center for Micro and Nanotechnologies, Lawrence Livermore National Laboratory, United States
Dr. Reginald Beer is the Medical Diagnostics Initiative Leader at Lawrence Livermore National Laboratory where he develops Lab-on-Chip technologies for time-critical Molecular Diagnostics applications.His interest in real-time detection is focused on supplying the physician or emergency responder with tools for rapid and accurate diagnostics. His research and publications in digital PCR, on-chip miniaturization, and rapid amplification have lead to several new technologies for improved diagnostics applications and outcomes.
Burkhard Brandt, Ph.D., Department of Tumor Biology, University Medical Center Hamburg-Eppendorf, Germany
Christopher Campbell, West Midlands Regional Genetics Laboratory, Birmingham Women’s Hospital, United Kingdom
Philippe Corbisier, Ph.D., Scientific and Technical Project Manager, Standards for Innovation and Sustainable Development, European Commission - JRC - IRMM, Belgium
Dr. Philippe Corbisier got his Ph.D. in cellular biochemistry in 1990 and has been working 11 years in molecular microbiology before joining the European Commission where he is managing the Biotech laboratory since 2001 and mainly interested in metrological aspect governing nucleic acids quantification.
Curtis Hughesman, Ph.D., Post-Doctoral Research Fellow, Michael Smith Laboratories, University of British Columbia, Canada
Dr. Hughesman recently completed his Ph.D. in Chemical and Biological Engineering at the Michael Smith Laboratories at UBC. His work has focused on the development of powerful new models for predicting the stability of natural and chemically modified duplex DNA. Over the last few years he has worked closely with the B.C. Cancer Agency to invent robust and cost-effective techniques for sensitive and specific detection of mutations in genomic DNA associated with the development and progression of cancer. Clinical assays based on this technology are now used by the Cancer Genetics Laboratory of the British Columbia Cancer Agency to analyze patient samples and thereby improve patient care while containing costs.
Guy Kiddle, Ph.D., Senior Molecular Biologist, IVD Technologies, Lumora Ltd., United Kingdom
Dr. Guy Kiddles’ research remit currently focuses on the development of affordable, rapid and simple approaches for molecular diagnosis that can be applied to high throughput and point-of care scenarios. Guy received his Ph.D. in Biotechnology from the University of Bristol, UK in 2004, before joining Lumora Ltd in July 2006, as a Senior Molecular Biologist. Before undertaking his present position he was a Post Doctorial Scientist at Rothamsted Research, affiliated to the Plant Biology and Crop Science Department, where he studied the molecular signaling networks of plants in response to stressful environments.
Ferdinando Mannello, Ph.D., Assistant Professor, Cell Biology, Department of Biomolecular Sciences, Section of Clinical Biochemistry and Cell Biology, University “Carlo Bo” of Urbino, Italy
Ferdinando Mannello received his Doctor of Biological Sciences degree cum Laude in 1982 from the University of Urbino (PU, Italy), with an experimental thesis entitled "Clinical biochemistry of human breast cyst fluids" performed in the labs of the Institute of Histology and Laboratory Analysis of the Faculty of Sciences. He worked as contract researcher in the same Institute and learned several biomedical technologies, in order to study structural and enzymatic proteins in breast cyst fluids needle-aspirated from healthy and diseased women affected by gross cystic breast disease. Successively, he appointed as Researcher in the field of cellular and clinical biochemistry of breast secretions, characterizing both nipple aspirate and breast cyst fluids through biochemical and morphological approaches; he corroborated the potential clinical interest of breast secretion protein analyses and identified subsets of women at risk for subsequent breast cancer through the bio-molecular characterization of Type II NAFs. Actually, he is the Vice-Chair of Research (of the ex-Institute of Histology and Laboratory Analysis now named Section of Clinical Biochemsitry-Unit of Cell Biology of the Dept of Biomolecular Sciences). As Assistant Professor is guiding his research group in the identification both the expression and cellular localization of several proteinases (like MMPs) involved in the preneoplastic transformation, proliferation and apoptosis. In particular, he focused attention to the role and involvement of Matrix Metallo-Proteinases in the human Chronic Venous Disease, studying the possible modulation of both proteinases and inflammatory markers by glycosaminoglycans (like Sulodexide).
Recently, he devotes his attention to Single-Cell Omics in human physiopathological processes.
He is the author of 150 peer reviewed full length scientific papers and 15 reviews; he is a Chairman of the Master of “Clinical Cell Analysis” of the University of Urbino “Carlo Bo”; Professor of Cytochemistry and Histochemistry at the Post-Doctoral School in "Molecular mechanisms of cell proliferation and differentiation" of the University of Urbino “Carlo Bo”; Professor of Molecular Diagnostic Pathology and Professor of Molecular Cytology at the Post-Doctoral School in “Biomedical technologies” of the Science Faculty of University of Urbino “Carlo Bo”; he is Referee of several clinical biochemistry and cell biology international Journals (e.g., British J Cancer, Cancer Res, Clinica Chimica Acta, Clinical Chemistry, Apoptosis, Int J Dev Biol, J Cell Biochem, J Cell Physiol, Cell Biol Toxicol, Srem Cells, Stem Cell Rev Rep, Cancer Microenvironment, Exp Rev Proteom, Pharmacogenomic J, BMC Medicine); he is Editor of some international Journals (e.g., Am J Transl Res, J Pharmacogenomic & Pharmacoproteomic, Recent Pat Anticanc Drug Discover, Breast Cancer Target Ther, J Cytology & Histology, BMC Cancer).
Gaia Schiavon, M.D., Ph.D., Cridlan Fellow in Medical Oncology – Breast Unit, The Royal Marsden NHS Foundation Trust, United Kingdom
Dr. Gaia Schiavon is a Medical Oncologist who specializes in the treatment of breast cancer.
After finishing her clinical training in Medical Oncology at the University Campus-Bio-Medico of Rome (Italy) in 2008, Dr. Schiavon worked in the Cell Biology department at Memorial Sloan-Kettering Cancer Center in New York and subsequently in the Translational Pharmacology Lab at Erasmus University Medical Center in Rotterdam (The Netherlands)completing a PhD in 2012.
Currently, a Clinical Fellow at Royal Marsden NHS Foundation Trust (Breast Unit), she also works in Dr Nicholas Turner’s Molecular Oncology Lab at the Institute of Cancer Research in London (United Kingdom).
Her main interests are the discovery of novel molecular factors predictive of response to therapy in breast cancer and the identification of newer imaging criteria for response assessment to treatment in solid tumors.
Thierry Voet, Ph.D., Head, Laboratory of Reproductive Genomics, KU Leuven, Belgium; Associate Faculty Member, Wellcome Trust Sanger Institute
Thierry Voet graduated as a Bio-engineer in Cell and Gene Biotechnology at the University of Leuven (KU Leuven, Belgium), and obtained his Ph.D. at the Faculty of Medicine.He was a visiting scientist in the Cancer Genome Project at the Wellcome Trust Sanger Institute (Hinxton-Cambridge, UK). Since 2009, Thierry Voet is assistant professor at the University of Leuven, and heads the Laboratory of Reproductive Genomics. Since 2011, he is also Associate Faculty member at the Wellcome Trust Sanger Institute (Hinxton, UK), and he is co-founder of the Sanger-EBI Single-Cell Genomics Centre (SCGC). Thierry’s team focuses on single-cell genomics projects and is part of SymBioSys that represents a KU Leuven Centre for Computational Systems Biology. He lectures undergraduates at KU Leuven on Human Embryology, Human Molecular Genetics, Hot Topics in Genetics and Initiation Scientific Education.
Gabriele Zoppoli, M.D., Ph.D., Internal Medicine Resident, University of Genova & IRCCS AOU San Martino IST, Italy